Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...

Nov. 11, 2002 — Hepatitis B surface antigen (HBsAg)-positive renal transplant patients have improved survival if they are preemptively treated with lamivudine, according to the results of a ...

There is a patient who needs a renal transplant fairly urgently as she is not tolerating hemodialysis. Two siblings are ready to donate kidneys. Unfortunately, both are HBsAg-positive (HBsAg+), but ...

Please provide your email address to receive an email when new articles are posted on . HBV-infected children treated with combination PEG-INF a-2b/nucleos(t)ide analogues achieved higher HBsAg loss ...

This large-scale exploratory study demonstrated that the prevalence of HDV antibody positivity was very low (0.24%) in Chinese patients with chronic HBV infection, with only one of the 4,936 patients ...

Q: If a person is exposed to potential bloodborne pathogens (e.g., inadvertently given another patient’s dialysate for hemodialysis), when is the best time to recheck for possible development of ...

Please provide your email address to receive an email when new articles are posted on . Among patients with low baseline HBsAg, 39% achieved HBsAg loss with tobevibart/elebsiran, which rose to 46% ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.